metlife inc. - MET

MET

Close Chg Chg %
100.02 -2.26 -2.26%

Closed Market

97.76

-2.26 (2.26%)

Volume: 4.31M

Last Updated:

Aug 7, 2026, 3:59 PM EDT

Company Overview: metlife inc. - MET

MET Key Data

Open

$99.39

Day Range

97.08 - 99.49

52 Week Range

67.33 - 100.93

Market Cap

$61.97B

Shares Outstanding

643.44M

Public Float

537.71M

Beta

0.77

Rev. Per Employee

N/A

P/E Ratio

18.63

EPS

$5.20

Yield

238.29%

Dividend

$0.59

EX-DIVIDEND DATE

Aug 4, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

4.03M

 

MET Performance

1 Week
 
1.71%
 
1 Month
 
6.68%
 
3 Months
 
25.22%
 
1 Year
 
28.19%
 
5 Years
 
61.04%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 99.267
Number of Ratings 22 Current Quarters Estimate 2.53
FY Report Date 09 / 2026 Current Year's Estimate 9.854
Last Quarter’s Earnings 2.28 Median PE on CY Estimate N/A
Year Ago Earnings 8.83 Next Fiscal Year Estimate 10.974
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 18 18
Mean Estimate 2.53 2.59 9.85 10.97
High Estimates 2.68 2.79 10.25 11.63
Low Estimate 2.41 2.38 9.55 10.60
Coefficient of Variance 2.37 4.02 1.63 2.53

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 12
OVERWEIGHT 3 3 2
HOLD 6 6 7
UNDERWEIGHT 2 2 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Mar 13, 2026 William E. Kennard Director 45,780 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 3,232,068.00
Mar 13, 2026 Robert Glenn Hubbard Director 104,630 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 7,386,878.00
Mar 13, 2026 Christian Mumenthaler Director 2,125 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 150,025.00
Mar 13, 2026 Carla A. Harris Director 9,764 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 689,338.40
Mar 13, 2026 Diana L. McKenzie Director 23,751 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 1,676,820.60
Mar 13, 2026 Jeh Charles Johnson Director 8,129 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 573,907.40
Mar 13, 2026 Laura J. Hay Director 4,971 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 350,952.60

Metlife Inc. in the News